The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global DNA Probes-Based Diagnostics Industry" - https://www.reportlinker.com/p098404/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global DNA Probes-Based Diagnostics Market to Reach $31.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for DNA Probes-Based Diagnostics estimated at US$14.9 Billion in the year 2022, is projected to reach a revised size of US$31.1 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2022-2030. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$18.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cancer segment is readjusted to a revised 10.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.4 Billion, While China is Forecast to Grow at 9% CAGR

The DNA Probes-Based Diagnostics market in the U.S. is estimated at US$4.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 8.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Select Competitors (Total 46 Featured)
- Abbott Molecular
- Beckman Coulter Inc.
- Becton, Dickinson and Company
- bioMérieux
- F. Hoffmann-La Roche Ltd.
- GE Healthcare Life Sciences
- Luminex Corporation
- QIAGEN N.V.
- Siemens Healthineers
- Thermo Fischer Scientific Inc.


Read the full report: https://www.reportlinker.com/p098404/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
What are DNA-Probes?
Recent Market Activity
DNA-based Diagnostics - A Prelude
DNA Tests: Finding Use in Numerous Applications
DNA Probes: Robust Growth Ahead
Developed Markets: Traditional Revenue Contributors
The United States: Unraveling the Country?s Edge in DNA-based
Diagnostics
Infectious Diseases Tests Dominate the DNA-based Diagnostics
Market
Developing Countries Excel in Growth Prospects
Decoding the Genetic Puzzle
Growth Drivers in a Nutshell
Growth Inhibitors in a Nutshell
Genetic Profiling of Pathogens: A Road Less Traveled
Roche’s Entry into the Hall of Molecular Fame
DNA Technology: An Evolutionary Scan
Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005
Market Opportunities
DNA Probes-Based Diagnostics - Global Key Competitors
Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS
Abbott Molecular (USA)
Beckman Coulter, Inc. (USA)
Becton, Dickinson and Company (USA)
bioMérieux (France)
F. Hoffmann-La Roche Ltd. (Switzerland)
GE Healthcare Life Sciences (UK)
Luminex Corporation (USA)
QIAGEN N.V. (Netherlands)
Siemens Healthineers (Germany)
Thermo Fisher Scientific, Inc. (USA)

3. MARKET TRENDS & DRIVERS
World’s Aging Population Drives the Popularity of DNA-Probe Tests
Global Aging Population Statistics - Opportunity Indicators
Rising Incidence of Chronic Diseases Fuels Demand for DNA
Probes Based Diagnostics
AIDS: A Global Epidemic
Rise in Healthcare Spending in Developing Nations Bode Well for
Market Growth
Reimbursements: "Under the Umbrella"
Evolution of New & Virulent Infectious Agents
Challenges in Widespread Deployment of DNA-based Diagnostics
DNA Probe Technology Gains Prominence in Diagnosing Vaginitis
Gene Banks - A Ray of Hope for the Future

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World Historic Review for DNA Probes-Based Diagnostics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 3: World 18-Year Perspective for DNA Probes-Based
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Infectious Diseases by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 5: World Historic Review for Infectious Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 6: World 18-Year Perspective for Infectious Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Cancer by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 8: World Historic Review for Cancer by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2021 and % CAGR

Table 9: World 18-Year Perspective for Cancer by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Genetic Predisposition by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 11: World Historic Review for Genetic Predisposition by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 12: World 18-Year Perspective for Genetic Predisposition
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 15: World 18-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Identity / Forensics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Identity / Forensics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 18: World 18-Year Perspective for Identity / Forensics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2023 & 2030

Table 19: World DNA Probes-Based Diagnostics Market Analysis of
Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2023
(E)
Table 20: USA Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 21: USA Historic Review for DNA Probes-Based Diagnostics
by Application - Infectious Diseases, Cancer, Genetic
Predisposition, Identity / Forensics and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2021 and % CAGR

Table 22: USA 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

CANADA
Table 23: Canada Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 24: Canada Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 25: Canada 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

JAPAN
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 26: Japan Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 27: Japan Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 28: Japan 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

CHINA
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2023 (E)
Table 29: China Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 30: China Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 31: China 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

EUROPE
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 32: Europe Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 33: Europe Historic Review for DNA Probes-Based
Diagnostics by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 34: Europe 18-Year Perspective for DNA Probes-Based
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2023 & 2030

Table 35: Europe Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 36: Europe Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 37: Europe 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

FRANCE
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2023 (E)
Table 38: France Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 39: France Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 40: France 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

GERMANY
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 41: Germany Recent Past, Current & Future Analysis for
DNA Probes-Based Diagnostics by Application - Infectious
Diseases, Cancer, Genetic Predisposition, Identity / Forensics
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: Germany Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 43: Germany 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

ITALY
Table 44: Italy Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 45: Italy Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 46: Italy 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

UNITED KINGDOM
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2023
(E)
Table 47: UK Recent Past, Current & Future Analysis for DNA
Probes-Based Diagnostics by Application - Infectious Diseases,
Cancer, Genetic Predisposition, Identity / Forensics and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 48: UK Historic Review for DNA Probes-Based Diagnostics
by Application - Infectious Diseases, Cancer, Genetic
Predisposition, Identity / Forensics and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2021 and % CAGR

Table 49: UK 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

REST OF EUROPE
Table 50: Rest of Europe Recent Past, Current & Future Analysis
for DNA Probes-Based Diagnostics by Application - Infectious
Diseases, Cancer, Genetic Predisposition, Identity / Forensics
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 51: Rest of Europe Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 52: Rest of Europe 18-Year Perspective for DNA
Probes-Based Diagnostics by Application - Percentage Breakdown
of Value Sales for Infectious Diseases, Cancer, Genetic
Predisposition, Identity / Forensics and Other Applications for
the Years 2012, 2023 & 2030

ASIA-PACIFIC
DNA Probes-Based Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 53: Asia-Pacific Recent Past, Current & Future Analysis
for DNA Probes-Based Diagnostics by Application - Infectious
Diseases, Cancer, Genetic Predisposition, Identity / Forensics
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 54: Asia-Pacific Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 55: Asia-Pacific 18-Year Perspective for DNA Probes-Based
Diagnostics by Application - Percentage Breakdown of Value
Sales for Infectious Diseases, Cancer, Genetic Predisposition,
Identity / Forensics and Other Applications for the Years 2012,
2023 & 2030

REST OF WORLD
Table 56: Rest of World Recent Past, Current & Future Analysis
for DNA Probes-Based Diagnostics by Application - Infectious
Diseases, Cancer, Genetic Predisposition, Identity / Forensics
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: Rest of World Historic Review for DNA Probes-Based
Diagnostics by Application - Infectious Diseases, Cancer,
Genetic Predisposition, Identity / Forensics and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 58: Rest of World 18-Year Perspective for DNA
Probes-Based Diagnostics by Application - Percentage Breakdown
of Value Sales for Infectious Diseases, Cancer, Genetic
Predisposition, Identity / Forensics and Other Applications for
the Years 2012, 2023 & 2030

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p098404/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001